Nomura Holdings’s Syndax Pharmaceuticals SNDX Stock Holding History

Nomura Holdings’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,849	Closed	-$421K	–	2383
2024 Q3	$421K	Buy	+21,849	New	+$451K	﹤0.01%	1286

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Nomura Holdings's SNDX Position: Q4 2024 in Review

Nomura Holdings sold out of Syndax Pharmaceuticals (SNDX) in Q4 2024, closing a stake of 21,849 shares — an estimated $421K sold.

Nomura Holdings first reported a position in SNDX in Q3 2024 and held it in 1 quarter. The position peaked at $421K in Q3 2024. 215 funds tracked by Wall St. Rank hold SNDX as of Q4 2024.

Nomura Holdings reported no remaining Syndax Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Nomura Holdings sold 21,849 Syndax Pharmaceuticals shares in Q4 2024, an estimated $421K.
Nomura Holdings first reported a position in Syndax Pharmaceuticals in Q3 2024 and held it in 1 quarter.
Nomura Holdings's Syndax Pharmaceuticals position peaked at $421K in Q3 2024.
215 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2024.

Based on Nomura Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.